Biomarkers of suicide: Predicting the predictable?

Understanding Suicide: From Diagnosis to Personalized Treatment

Volumn , Issue , 2016, Pages 77-83

  Blasco Fontecilla, Hilario ^a   Oquendo, Maria A ^b  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84978301559     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-319-26282-6_7     Document Type: Chapter

References (43)

1. Asberg M, Traskman L, Thoren P (1976) 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? Arch Gen Psychiatry 33:1193-1197
2. Banerjee R, Ghosh AK, Ghosh B, Bhattacharyya S, Mondal AC (2013) Decreased mRNA and protein expression of BDNF, NGF, and their receptors in the hippocampus from suicide: an analysis in human postmortem brain. Clin Med Insights Pathol 6:1-11
3. Bayard-Burfield L, Alling C, Blennow K, Jonsson S, Traskman-Bendz L (1996) Impairment of the blood-CSF barrier in suicide attempters. Eur Neuropsychopharmacol 6:195-199
4. Blasco-Fontecilla H, Lopez-Castroman J, Giner L, Baca-Garcia E, Oquendo MA (2013) Predicting suicidal behavior: are we really that far along? Comment on "Discovery and validation of blood biomarkers for suicidality". Curr Psychiatry Rep 15:424
5. Braquehais MD, Picouto MD, Casas M, Sher L (2012) Hypothalamic-pituitary-adrenal axis dysfunction as a neurobiological correlate of emotion dysregulation in adolescent suicide. World J Pediatr 8:197-206
6. Brower V (2011) Biomarkers: portents of malignancy. Nature 471:S19-S21
7. Coryell W, Schlesser M (2001) The dexamethasone suppression test and suicide prediction. Am J Psychiatry 158:748-753
8. Coryell W, Schlesser M (2007) Combined biological tests for suicide prediction. Psychiatry Res 150:187-191
9. Davis AT, Schrueder C (1990) The prediction of suicide. Med J Aust 153:552-554
10. Duman RS, Monteggia LM (2006) A neurotrophic model for stress-related mood disorders. Biol Psychiatry 59:1116-1127
11. Dwivedi Y, Rizavi HS, Conley RR, Roberts RC, Tamminga CA, Pandey GN (2003) Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry 60:804-815
12. Falcone T, Fazio V, Lee C, Simon B, Franco K, Marchi N, Janigro D (2010) Serum S100B: a potential biomarker for suicidality in adolescents? PLoS One 5:e11089
13. Fawcett J, Busch KA, Jacobs D, Kravitz HM, Fogg L (1997) Suicide: a four-pathway clinicalbiochemical model. Ann N Y Acad Sci 836:1981
14. Gerszten RE, Wang TJ (2008) The search for new cardiovascular biomarkers. Nature 451:949-952
15. Golier JA, Marzuk PM, Leon AC, Weiner C, Tardiff K (1995) Low serum cholesterol level and attempted suicide. Am J Psychiatry 152:419-423
16. Jokinen J, Carlborg A, Martensson B, Forslund K, Nordstrom AL, Nordstrom P (2007) DST nonsuppression predicts suicide after attempted suicide. Psychiatry Res 150:297-303
17. Jokinen J, Martensson B, Nordstrom AL, Nordstrom P (2008) CSF 5-HIAA and DST nonsuppression -independent biomarkers in suicide attempters? J Affect Disord 105:241-245
18. Jokinen J, Nordstrom AL, Nordstrom P (2009) Cerebrospinal fluid monoamine metabolites and suicide. Nord J Psychiatry 63:276-279
19. Jollant F, Lawrence NL, Olie E, Guillaume S, Courtet P (2011) The suicidal mind and brain: a review of neuropsychological and neuroimaging studies. World J Biol Psychiatry 12:319-339
20. Jones R (2010) Biomarkers: casting the net wide. Nature 466:S11-S12
21. Kim YK, Myint AM (2004) Clinical application of low serum cholesterol as an indicator for suicide risk in major depression. J Affect Disord 81:161-166
22. Lee BH, Kim YK (2011) Potential peripheral biological predictors of suicidal behavior in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 35:842-847
23. Lee JM, Han JJ, Altwerger G, Kohn EC (2011) Proteomics and biomarkers in clinical trials for drug development. J Proteomics 74:2632-2641
24. Le-Niculescu H, Levey DF, Ayalew M, Palmer L, Gavrin LM, Jain N, Winiger E, Bhosrekar S, Shankar G, Radel M, Bellanger E, Duckworth H, Olesek K, Vergo J, Schweitzer R, Yard M, Ballew A, Shekhar A, Sandusky GE, Schork NJ, Kurian SM, Salomon DR, Niculescu AB 3rd (2013) Discovery and validation of blood biomarkers for suicidality. Mol Psychiatry 18:1249-1264
25. Lester D (1995) The concentration of neurotransmitter metabolites in the cerebrospinal fluid of suicidal individuals: a meta-analysis. Pharmacopsychiatry 28:45-50
26. Lindberg G, Rastam L, Gullberg B, Eklund GA (1992) Low serum cholesterol concentration and short term mortality from injuries in men and women. BMJ 305:277-279
27. Mann JJ, Currier D (2007) A review of prospective studies of biologic predictors of suicidal behavior in mood disorders. Arch Suicide Res 11:3-16
28. Mann JJ, Waternaux C, Haas GL, Malone KM (1999) Toward a clinical model of suicidal behavior in psychiatric patients. Am J Psychiatry 156:181-189
29. Mann JJ, Currier D, Stanley B, Oquendo MA, Amsel LV, Ellis SP (2006) Can biological tests assist prediction of suicide in mood disorders? Int J Neuropsychopharmacol 9:465-474
30. McIntyre RS, Muzina DJ, Kemp DE, Blank D, Woldeyohannes HO, Lofchy J, Soczynska JK, Banik S, Konarski JZ (2008) Bipolar disorder and suicide: research synthesis and clinical translation. Curr Psychiatry Rep 10:66-72
31. Meijer OC, De Kloet ER (1998) Corticosterone and serotonergic neurotransmission in the hippocampus:functional implications of central corticosteroid receptor diversity. Crit Rev Neurobiol 12:1-20
32. Oquendo MA, Sullivan GM, Sudol K, Baca-Garcia E, Stanley BH, Sublette ME, Mann JJ (2014) Toward a biosignature for suicide. Am J Psychiatry 171:1259-1277
33. Papadopoulou A, Markianos M, Christodoulou C, Lykouras L (2013) Plasma total cholesterol in psychiatric patients after a suicide attempt and in follow-up. J Affect Disord 148:440-443
34. Poudel-Tandukar K, Nanri A, Iwasaki M, Mizoue T, Matsushita Y, Takahashi Y, Noda M, Inoue M, Tsugane S (2011) Long chain n-3 fatty acids intake, fish consumption and suicide in a cohort of Japanese men and women -the Japan Public Health Center-based (JPHC) prospective study. J Affect Disord 129:282-288
35. Sher L, Carballo JJ, Grunebaum MF, Burke AK, Zalsman G, Huang YY, Mann JJ, Oquendo MA (2006) A prospective study of the association of cerebrospinal fluid monoamine metabolite levels with lethality of suicide attempts in patients with bipolar disorder. Bipolar Disord 8:543-550
36. Singh I, Rose N (2009) Biomarkers in psychiatry. Nature 460:202-207
37. Smith EG, Kim HM, Ganoczy D, Stano C, Pfeiffer PN, Valenstein M (2013) Suicide risk assessment received prior to suicide death by Veterans Health Administration patients with a history of depression. J Clin Psychiatry 74:226-232
38. Sublette ME, Hibbeln JR, Galfalvy H, Oquendo MA, Mann JJ (2006) Omega-3 polyunsaturated essential fatty acid status as a predictor of future suicide risk. Am J Psychiatry 163:1100-1102
39. Sunnqvist C, Westrin A, Traskman-Bendz L (2008) Suicide attempters: biological stressmarkers and adverse life events. Eur Arch Psychiatry Clin Neurosci 258:456-462
40. Traskman L, Asberg M, Bertilsson L, Sjostrand L (1981) Monoamine metabolites in CSF and suicidal behavior. Arch Gen Psychiatry 38:631-636
41. Tsai AC, Lucas M, Okereke OI, O’Reilly EJ, Mirzaei F, Kawachi I, Ascherio A, Willett WC (2014) Suicide mortality in relation to dietary intake of n-3 and n-6 polyunsaturated fatty acids and fish: equivocal findings from 3 large US cohort studies. Am J Epidemiol 179:1458-1466
42. Zhang L, Su TP, Choi K, Maree W, Li CT, Chung MY, Chen YS, Bai YM, Chou YH, Barker JL, Barrett JE, Li XX, Li H, Benedek DM, Ursano R (2011) P11 (S100A10) as a potential biomarker of psychiatric patients at risk of suicide. J Psychiatr Res 45:435-441
43. Zureik M, Courbon D, Ducimetiere P (1996) Serum cholesterol concentration and death from suicide in men: Paris prospective study I. BMJ 313:649-651